Patents by Inventor Kazunori Imaizumi

Kazunori Imaizumi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for regulating cell proliferation
    Patent number: 9695235
    Abstract: The present invention provides a composition for regulating cell proliferation comprising a peptide having a partial amino acid sequence of BBF2H7 or an antibody capable of binding to the peptide. The problem has been solved by preparation of the peptide having a partial amino acid sequence of BBF2H7 which has a cell proliferation activity.
    Type: Grant
    Filed: August 28, 2013
    Date of Patent: July 4, 2017
    Assignee: Hiroshima University
    Inventors: Kazunori Imaizumi, Atsushi Saito
  • Method for Regulating Cell Proliferation
    Publication number: 20160326246
    Abstract: The present invention provides a composition for regulating cell proliferation comprising a peptide having a partial amino acid sequence of BBF2H7 or an antibody capable of binding to the peptide. The problem has been solved by preparation of the peptide having a partial amino acid sequence of BBF2H7 which has a cell proliferation activity.
    Type: Application
    Filed: July 28, 2016
    Publication date: November 10, 2016
    Applicant: Hiroshima University
    Inventors: Kazunori Imaizumi, Atsushi Saito
  • Method for Regulating Cell Proliferation
    Publication number: 20150225469
    Abstract: The present invention provides a composition for regulating cell proliferation comprising a peptide having a partial amino acid sequence of BBF2H7 or an antibody capable of binding to the peptide. The problem has been solved by preparation of the peptide having a partial amino acid sequence of BBF2H7 which has a cell proliferation activity.
    Type: Application
    Filed: August 28, 2013
    Publication date: August 13, 2015
    Applicant: Hiroshima University
    Inventors: Kazunori Imaizumi, Atsushi Saito
  • Oasis gene-deficient mouse
    Patent number: 7847148
    Abstract: A mouse that is deficient in the function of the gene for OASIS, and a method for screening for, or evaluating a pharmacological efficacy of, therapeutic agents for osteoporosis using the mouse.
    Type: Grant
    Filed: September 25, 2006
    Date of Patent: December 7, 2010
    Assignee: University of Miyazaki
    Inventors: Kazunori Imaizumi, Shinichi Kondo, Akio Wanaka
  • OASIS GENE-DEFICIENT MOUSE
    Publication number: 20090019556
    Abstract: A mouse that is deficient in the function of the gene for OASIS, and a method for screening for, or evaluating a pharmacological efficacy of, therapeutic agents for osteoporosis using the mouse.
    Type: Application
    Filed: September 25, 2006
    Publication date: January 15, 2009
    Inventors: Kazunori Imaizumi, Shinichi Kondo, Akio Wanaka
  • Nucleic acid participating in the formation of presenilin-2-gene exon 5-defective splicing variant
    Patent number: 7364847
    Abstract: The present invention provides a means for treatment and/or prevention of a disease caused by aberrant splicing, a neurodegenerative disease represented by Alzheimer's disease, or the like. The present invention relates to a nucleic acid which can be associated with generation of a splice variant that lacks exon 5 of presenilin-2 gene, an inhibitor for inhibiting a binding between protein-nucleic acid caused by aberrant splicing, and a method for screening the inhibitor.
    Type: Grant
    Filed: June 27, 2002
    Date of Patent: April 29, 2008
    Assignee: Japan Science and Tehcnology Agency
    Inventors: Masaya Tohyama, Taiichi Katayama, Takayuki Manabe, Kazunori Imaizumi, Yoko Ikeda
  • Medicinal compositions
    Publication number: 20050065102
    Abstract: To provide a means useful for treating or preventing a disease such as a brain disorder or a neurodegenerative disease even more efficiently and even more sustainedly. The present invention relates to an inhibitor capable of inhibiting a binding between HMG-I protein and exon 5 of presenilin-2 mRNA, an agent for suppressing neuronal death, capable of suppressing neuronal death, a pharmaceutical composition which is useful for treatment or prevention of a disease caused by the generation of a splice variant that lacks exon 5 of presenilin-2 mRNA, a method for treating or preventing the disease and a use of the inhibitor.
    Type: Application
    Filed: June 27, 2002
    Publication date: March 24, 2005
    Inventors: Masaya Tohyama, Taiichi Katayama, Takayuki Manabe, Kazunori Imaizumi, Yoko Ikeda
  • Nucleic acid participating in the formation of presenilin-2-gene exon 5-defective splicing variant
    Publication number: 20040267004
    Abstract: The present invention provides a means for treatment and/or prevention of a disease caused by aberrant splicing, a neurodegenerative disease represented by Alzheimer's disease, or the like. The present invention relates to a nucleic acid which can be associated with generation of a splice variant that lacks exon 5 of presenilin-2 gene, an inhibitor for inhibiting a binding between protein-nucleic acid caused by aberrant splicing, and a method for screening the inhibitor.
    Type: Application
    Filed: December 24, 2003
    Publication date: December 30, 2004
    Inventors: Masaya Tohyama, Taiichi Katayama, Takayuki Manabe, Kazunori Imaizumi, Yoko Ikeda